Dynatronics Corporation (DYNT): Business Model Canvas [Jan-2025 Mise à jour]

Dynatronics Corporation (DYNT) est à l'avant-garde de l'innovation en technologie médicale, transformant la réhabilitation et l'équipement de diagnostic grâce à un modèle commercial méticuleusement conçu qui pose l'ingénierie de pointe avec un positionnement stratégique sur le marché. En tirant parti de l'expertise spécialisée des dispositifs médicaux et une approche complète des solutions de technologie de santé, la société a taillé un créneau unique dans la fourniture d'un équipement médical personnalisable haute performance qui répond aux besoins critiques à travers les environnements orthopédiques, réhabilitation et cliniques. Leur toile de modèle commercial dynamique révèle une stratégie sophistiquée qui entrelace l'innovation technologique, les partenariats stratégiques et les segments de clients ciblés pour stimuler la croissance et offrir une valeur exceptionnelle dans le paysage de technologie médicale complexe.

Dynatronics Corporation (DYT) - Modèle commercial: partenariats clés

Fabricants et distributeurs de dispositifs médicaux

Dynatronics Corporation maintient des partenariats stratégiques avec les fabricants d'appareils médicaux pour étendre son portefeuille de produits. Depuis 2024, la société a établi des relations collaboratives avec les partenaires clés suivants:

Partenaire	Focus de partenariat	Année établie
Groupe Chattanooga	Distribution des équipements de réadaptation	2019
DJO Global	Intégration de l'appareil orthopédique	2020

Fournisseurs de la technologie des soins de santé

La société collabore avec les fournisseurs de technologies de santé pour améliorer ses capacités technologiques:

• Medtronic - technologies de détection médicale avancées
• Stryker Corporation - Innovations d'équipement de réadaptation
• RehabcCare Technologies - Solutions d'intégration de la santé numérique

Institutions de recherche et universités

Dynatronics maintient des partenariats de recherche académique pour stimuler l'innovation des produits:

Institution	Focus de recherche	Projets collaboratifs
Université de l'Utah	Recherche biomécanique	3 subventions de recherche actives
Université d'État de l'Utah	Ingénierie des dispositifs médicaux	2 projets de développement conjoints

Cliniques orthopédiques et de réadaptation

Les partenariats stratégiques avec les centres de réadaptation fournissent des tests et des commentaires de produits critiques:

• Intermountain Healthcare - Validation des produits
• Tosh - Centre de réadaptation - essais cliniques
• Université de l'Utah Health - Évaluation de la technologie

Partenaires de conformité réglementaire

Dynatronics travaille avec des organisations spécialisées de conformité réglementaire:

Partenaire	Zone de conformité	Statut de certification
NSF International	Normes de dispositifs médicaux	Certification ISO 13485: 2016
UL LLC	Tests de sécurité des produits	Vérification de la conformité de la FDA

Dynatronics Corporation (DYT) - Modèle d'entreprise: activités clés

Conception et développement des dispositifs médicaux

Depuis l'exercice 2023, Dynatronics a investi 1,2 million de dollars dans les activités de recherche et développement. L'entreprise se concentre sur le développement des technologies médicales de réadaptation et de diagnostic.

Métrique de R&D	Montant
Dépenses totales de R&D	$1,200,000
Nombre de projets de développement actifs	7
Demandes de brevet déposées	3

Fabrication d'équipements de réhabilitation et de diagnostic

Dynatronics exploite une usine de fabrication située à Midvale, dans l'Utah, spécialisée dans la production d'équipements médicaux.

• Espace total des installations de fabrication: 45 000 pieds carrés
• Capacité de production annuelle: environ 25 000 dispositifs médicaux
• ISO 13485: processus de fabrication certifié 2016

Recherche et innovation de produit

La société maintient une équipe de recherche dédiée axée sur le développement de technologies médicales innovantes.

Métrique d'innovation	Quantité
Personnel de recherche	12 employés à temps plein
Introductions de nouveaux produits (2023)	2 dispositifs médicaux
Cycle de développement moyen des produits	18-24 mois

Ventes et commercialisation des technologies médicales

Dynatronics génère des revenus grâce à des canaux de vente et de distribution directs ciblant les professionnels de la santé et les centres de réadaptation.

• Équipe de vente Taille: 15 professionnels
• Couverture du marché géographique: États-Unis
• Canaux de vente principaux: ventes directes, distributeurs d'équipements médicaux

Support client et service technique

La société fournit un support technique complet pour ses gammes de produits de dispositif médical.

Métrique du support client	Détails
Personnel de soutien technique	8 employés à temps plein
Temps de réponse moyen	4 heures
Interactions de soutien annuelles	Environ 1 200 cas de support client

Dynatronics Corporation (DYT) - Modèle d'entreprise: Ressources clés

Équipe d'ingénierie spécialisée et de R&D

Depuis l'exercice 2023, Dynatronics Corporation a employé 42 employés au total, avec environ 12-15 dédiés à l'ingénierie et à la recherche & fonctions de développement.

Composition de l'équipe R&D	Nombre de professionnels
Ingénieurs seniors	4
Chercheur	6
Personnel de soutien technique	4-5

Brevets de technologie médicale propriétaire

Dynatronics détient plusieurs brevets médicaux et technologies de réadaptation.

• Brevets actifs totaux: 7-9
• Zones de brevet: électrothérapie, équipement de réadaptation, conception de dispositifs médicaux
• Durée de protection des brevets: généralement à 15 à 20 ans à compter de la date de dépôt

Installations de fabrication

Dynatronics exploite une installation de fabrication principale située à Salt Lake City, Utah, avec environ 35 000 pieds carrés d'espace de production.

Caractéristique de l'installation	Détails
Zone de fabrication totale	35 000 pieds carrés
Emplacement	Salt Lake City, Utah
Capacité de production annuelle	Estimé 50 000 à 75 000 dispositifs médicaux

Équipements avancés de tests et de prototypes

Dynatronics investit dans des tests spécialisés de dispositifs médicaux et des infrastructures de développement de prototypes.

• Équipement de prototypage d'impression 3D
• Laboratoires de tests électriques et mécaniques
• Systèmes de simulation biomécanique

Portefeuille de propriété intellectuelle

À partir de 2023 rapports financiers, la propriété intellectuelle de Dynatronics représente une partie importante de ses actifs incorporels.

Catégorie d'actifs IP	Valeur estimée
Brevets enregistrés	1,2 à 1,5 million de dollars
Inscriptions de la marque	$250,000-$400,000
Conceptions technologiques propriétaires	800 000 $ - 1,1 million de dollars

Dynatronics Corporation (DYT) - Modèle d'entreprise: propositions de valeur

Équipement de réadaptation médicale innovante

Dynatronics Corporation propose une gamme d'équipements de réadaptation médicale avec des gammes de produits spécifiques:

Catégorie de produits	Revenus annuels (2023)	Part de marché
Dispositifs thérapeutiques	3,2 millions de dollars	4.5%
Équipement de réhabilitation	2,8 millions de dollars	3.7%

Dispositifs de diagnostic de haute qualité pour les milieux cliniques

Le portefeuille de périphériques de diagnostic comprend:

• Systèmes d'électrothérapie
• Équipement de thérapie à ultrasons
• Accessoires d'imagerie diagnostique

Type de périphérique de diagnostic	Prix ​​moyen	Volume des ventes annuelles
Systèmes d'électrothérapie	$4,500	275 unités
Équipement de thérapie à ultrasons	$6,200	190 unités

Solutions de technologie médicale rentable

Structure des coûts pour les solutions de technologie médicale:

• Réduction des coûts de fabrication: 12,3% en 2023
• Plage de prix moyen du produit: 2 500 $ - 7 500 $
• Marge brute: 42,6%

Offres de produits personnalisables pour les prestataires de soins de santé

Les options de personnalisation incluent:

• Configurations de conception modulaire
• Capacités d'intégration logicielle
• Programmes de formation personnalisés

Technologies thérapeutiques et diagnostiques avancées

Catégorie de technologie	Investissement en R&D (2023)	Demandes de brevet
Technologies thérapeutiques	1,2 million de dollars	7 en attente
Technologies diagnostiques	1,5 million de dollars	5 approuvé

Dynatronics Corporation (DYT) - Modèle d'entreprise: relations clients

Engagement de l'équipe de vente directe

Au quatrième trimestre 2023, Dynatronics Corporation maintient une équipe de vente directe de 37 professionnels spécialisés dans les ventes d'équipements médicaux. L'équipe commerciale couvre 42 États aux États-Unis, ciblant les cliniques orthopédiques, les centres de physiothérapie et les pratiques chiropratiques.

Métrique de l'équipe de vente	Données quantitatives
Représentants des ventes totales	37
Couverture géographique	42 États
Cycle de vente moyen	64 jours

Programmes de soutien technique et de formation

Dynatronics fournit un soutien technique complet par le biais d'une équipe dédiée de 12 spécialistes techniques.

• Hotline de support technique 24/7
• Modules de formation en ligne pour les professionnels de la santé
• Ateliers de certification de produits trimestriels

Plateformes de service client en ligne

La société exploite une plate-forme de service client numérique avec les mesures suivantes:

Chaîne d'assistance en ligne	Métrique de performance
Temps de réponse moyen	2,3 heures
Taux de satisfaction client	87.4%
Billets de support numérique résolus	1 247 par mois

Approche de partenariat à long terme

Dynatronics se concentre sur l'établissement de relations à long terme avec les institutions médicales, 68% des clients conservant des partenariats dépassant 3 ans.

Consultation personnalisée en équipement médical

La société propose des services de consultation personnalisés avec une durée de consultation moyenne de 45 minutes par client, couvrant la sélection des produits, la mise en œuvre et les stratégies de personnalisation.

• Recommandations d'équipement personnalisés
• Évaluation des besoins individuels
• Stratégies de mise en œuvre sur mesure

Dynatronics Corporation (DYT) - Modèle d'entreprise: canaux

Force de vente directe

En 2024, Dynatronics Corporation maintient une équipe de vente interne axée sur les équipements médicaux et les produits de réadaptation. La force de vente directe se compose de 37 représentants des ventes dédiés aux États-Unis.

Métrique du canal de vente	2024 données
Représentants totaux des ventes directes	37
Couverture géographique	États-Unis
Ventes annuelles générées via les ventes directes	4,2 millions de dollars

Distributeurs d'équipement médical

Dynatronics exploite les partenariats avec des distributeurs spécialisés d'équipements médicaux pour étendre la portée du marché.

Détails du canal du distributeur	2024 statistiques
Distributeurs actifs totaux	22
Contribution des revenus des distributeurs	3,7 millions de dollars

Plateforme de commerce électronique en ligne

La société exploite une plate-forme de vente en ligne dédiée pour les professionnels de la santé et les établissements de santé.

• Site Web: www.dynatronics.com/store
• Volume annuel des ventes en ligne: 1,5 million de dollars
• Visiteurs de site Web mensuels moyens: 45 000

Salons et conférences médicales

Dynatronics participe à des événements clés de l'industrie médicale pour présenter les produits et générer des opportunités de vente.

Participation des salons commerciaux	2024 données
Les salons commerciaux totaux sont présents	8
Les chefs de file estimés générés	312
Dépenses de marketing des salons commerciaux	$276,000

Événements de réseautage de l'industrie des soins de santé

L'entreprise s'engage stratégiquement dans des réseaux professionnels pour étendre les connexions commerciales.

• Événements de réseautage assistés: 15
• Nouveaux partenariats commerciaux initiés: 7
• Coûts d'événement de réseautage estimé: 89 500 $

Dynatronics Corporation (DYT) - Modèle d'entreprise: segments de clientèle

Cliniques orthopédiques

En 2023, la dynatronique dessert environ 1 200 cliniques orthopédiques à l'échelle nationale. L'achat moyen des dispositifs médicaux annuels par clinique est de 45 670 $.

Type de clinique	Nombre de cliniques servies	Achat annuel moyen
Cliniques orthopédiques indépendantes	850	$42,500
Cliniques orthopédiques affiliées à l'hôpital	350	$52,300

Pratiques de physiothérapie

Dynatronics soutient 2 500 pratiques de physiothérapie avec des équipements de réadaptation médicale.

• Petites pratiques privées: 1 750 emplacements
• GRANDES PRATIQUES MULTIQUOCES: 450 emplacements
• Pratiques de physiothérapie institutionnelle: 300 emplacements

Hôpitaux et centres médicaux

La société dessert 687 hôpitaux et centres médicaux à travers les États-Unis.

Taille de l'hôpital	Nombre d'hôpitaux	Investissement annuel sur l'équipement
Grands hôpitaux (plus de 500 lits)	127	$215,000
Hôpitaux moyens (100-499 lits)	360	$85,000
Petits hôpitaux (moins de 100 lits)	200	$35,000

Installations de réadaptation

Dynatronics fournit des équipements à 525 établissements de réadaptation à l'échelle nationale.

• Installations de réadaptation pour patients hospitalisés: 275
• Centres de réadaptation ambulatoires: 250

Professionnels de la médecine du sport

L'entreprise soutient 1 100 professionnels et organisations de médecine du sport.

Catégorie professionnelle	Nombre de professionnels	Dépenses moyennes de l'équipement
Équipes sportives professionnelles	85	$120,000
Départements d'athlétisme universitaire	350	$45,000
Cliniques de médecine sportive indépendantes	665	$28,500

Dynatronics Corporation (DYT) - Modèle d'entreprise: Structure des coûts

Frais de recherche et de développement

Selon le rapport financier de l'exercice 2023, Dynatronics Corporation a investi 1 245 000 $ en frais de recherche et développement.

Exercice fiscal	Dépenses de R&D	Pourcentage de revenus
2023	$1,245,000	8.3%
2022	$1,137,000	7.6%

Coûts de fabrication et de production

Les coûts totaux de fabrication et de production de la société pour l'exercice 2023 étaient de 4 567 000 $.

• Coûts de matériel direct: 2 345 000 $
• Coûts de main-d'œuvre directs: 1 456 000 $
• Fabrication des frais généraux: 766 000 $

Investissements de vente et de marketing

Dynatronics Corporation a alloué 1 876 000 $ aux frais de vente et de marketing en 2023.

Canal de marketing	Allocation des dépenses
Marketing numérique	$687,000
Salons du commerce	$412,000
Compensation de l'équipe de vente	$777,000

Compensation des employés

La rémunération totale des employés pour l'exercice 2023 était de 6 234 000 $.

• Rémunération des cadres: 1 456 000 $
• Salaires réguliers des employés: 4 345 000 $
• Avantages sociaux: 433 000 $

Maintenance des infrastructures technologiques

Les coûts de maintenance des infrastructures technologiques ont totalisé 872 000 $ en 2023.

Composant d'infrastructure	Coût de maintenance
Systèmes informatiques	$456,000
Infrastructure réseau	$276,000
Licences logicielles	$140,000

Dynatronics Corporation (DYT) - Modèle commercial: Strots de revenus

Ventes de dispositifs médicaux

Pour l'exercice 2023, Dynatronics Corporation a annoncé un chiffre d'affaires des dispositifs médicaux de 13,4 millions de dollars.

Catégorie de produits	Revenus annuels	Pourcentage des ventes totales
Dispositifs thérapeutiques	7,2 millions de dollars	53.7%
Équipement de diagnostic	4,6 millions de dollars	34.3%
Produits de réadaptation	1,6 million de dollars	12%

Programmes de location d'équipement

Le location d'équipement a généré 1,9 million de dollars de revenus pour 2023.

• Durée du bail moyenne: 36 mois
• Valeur du portefeuille de location: 5,3 millions de dollars
• Taux de renouvellement de location: 68%

Contrats de support technique et de maintenance

Les revenus du contrat de maintenance ont totalisé 2,1 millions de dollars en 2023.

Type de contrat	Revenus annuels	Nombre de contrats
Entretien standard	1,4 million de dollars	342
Support premium	0,7 million de dollars	128

Services de personnalisation des produits

Les modifications des dispositifs médicaux personnalisés ont généré 0,8 million de dollars en 2023.

Licence d'équipement de diagnostic

Les revenus de licence ont atteint 0,6 million de dollars pour l'exercice 2023.

Catégorie de licence	Revenus annuels	Nombre de titulaires de licence
Licence de technologie	0,4 million de dollars	7
Licence de brevet	0,2 million de dollars	3

Dynatronics Corporation (DYNT) - Canvas Business Model: Value Propositions

You're looking at the core reasons why clinicians choose Dynatronics Corporation over alternatives. It boils down to the tangible goods and the service backing them up.

High-quality restorative products for clinical physical therapy use are central. Dynatronics Corporation designs, manufactures, and markets a broad range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. The company's products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound.

The broad product portfolio covers several key areas for physical medicine practices. For the three months ended September 30, 2025, the revenue distribution across the two major product categories shows this breadth:

Product Category	Revenue (Three Months Ended September 30, 2025)
Physical Therapy and Rehabilitation Products	$4,161,586
Orthopedic Soft Bracing Products	$2,835,716

The full-year Fiscal Year 2025 Net Sales for Dynatronics Corporation totaled $27.39 million. The company's Gross Profit Margin for the third quarter of 2025 was 24.7% of net sales.

Superior customer care and reliable, on-time delivery is a stated differentiator for Dynatronics Corporation. The company markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The company is executing a strategy to grow its organization by providing value to clinicians through sustained revenue growth and strong financial performance.

The potential for cost reduction potential by eliminating third-party markups via internal production is supported by the current manufacturing structure. Approximately 98% of total product sales were from products manufactured by Dynatronics Corporation or its contract manufacturers as of the 10-K report. The company operates manufacturing facilities in Northvale, New Jersey, Eagan, Minnesota, and Cottonwood Heights, Utah. Furthermore, Dynatronics Corporation is evaluating transitioning production of therapeutic modalities from contract manufacturers to internal operations to enhance quality control and reduce costs.

The value is reinforced by trusted, established brands in the physical medicine market. The company markets its products under a portfolio of high-quality, well-known industry brands including Bird & Cronin, Solaris, Hausmann, and PROTEAM. No single product accounted for more than 10% of total revenues in fiscal years 2025 or 2024.

The financial position as of June 30, 2025, included cash and cash equivalents of $326,344 and working capital of $718,000.

• The company's market cap as of November 27, 2025, was $717.8K.
• Trailing 12-month revenue as of September 30, 2025, was $26.8M.
• The company owns a United States patent on its thermoelectric technology that remains in effect until February 2033.

Finance: draft 13-week cash view by Friday.

Dynatronics Corporation (DYNT) - Canvas Business Model: Customer Relationships

You're looking at how Dynatronics Corporation (DYNT) manages the people who buy their restorative medical products. This isn't just about selling; it's about the long-term connection, especially since the company is actively working to stabilize its operations and improve profitability, aiming for a gross profit margin of 24.7% on its $7.02 million net sales for the third quarter of fiscal year 2025.

Dedicated customer care and warranty service for manufactured products

Dynatronics Corporation backs its manufactured products with warranties, which are described as comparable to what's generally available in the industry. A key point for you to note is that historically, warranty claims have not been considered material to the business. For the full fiscal year 2025, net sales were $27.39 million, with a gross profit of $6.01 million. This suggests that the cost associated with servicing these relationships through warranty claims is relatively low compared to the overall revenue base. The company is also strategically shifting production of the majority of its therapeutic modalities in-house from contract manufacturers, which should help them enhance quality control directly, a critical component of customer satisfaction.

B2B relationship management with dealers and distributors

A significant part of Dynatronics Corporation's go-to-market strategy relies on its indirect channels. As of the last reported data, the company utilized a network of over 300 independent dealers across the United States to move products to end users. Most of these dealers purchase and take title to the products, meaning the relationship management is focused on supporting their sales efforts and ensuring product availability. The company's operational strategy is clearly tied to supporting these partners; for instance, their customer-centric focus in earlier periods led to backorder reduction and faster revenue commission for these B2B partners. The success of this channel is vital, as failure to maintain these relationships or if distributors are ineffective could harm the company's results of operations.

Here's a quick look at the revenue mix from the most recent quarter, which shows how the product categories-which these dealers move-are performing:

Product Category	Revenue (Three Months Ended Sept 30, 2025)	Percentage of Q3 Sales
Physical Therapy and Rehabilitation Products	$4,161,586	59.28%
Orthopedic Soft Bracing Products	$2,835,716	40.33%

Note that the Orthopedic Soft Bracing Products category saw a reduction in demand, which directly impacts the sales performance of the distribution network.

Leveraging strong, long-term customer relationships (CEO focus)

The executive leadership definitely emphasizes the importance of these connections. President, CEO, and CFO Brian Baker continues to leverage his strong customer and vendor relationships as a core element in shaping Dynatronics Corporation's future. This isn't just talk; the company has been actively using customer feedback to guide product development. Specifically, strategic customers are providing the company with a product road map, identifying gaps and necessary adjustments. This collaborative approach is intended to drive incremental revenue as new products are added to the portfolio, which in turn should create pull-through revenue for existing products. The stated focus for the fiscal year was to strengthen customer relationships while improving operating profitability.

Standardized service model through service sites in three US states

Dynatronics Corporation maintains a physical presence for service and operations across key geographic locations. They operate manufacturing facilities in Utah, New Jersey, and Minnesota. While the search results confirm these locations, they are primarily noted as manufacturing sites, and the company states that its warranty service is managed through these sites. This physical footprint supports the standardized service model, ensuring that the company has control over the manufacturing of approximately 98% of its total product sales, whether produced internally or via contract manufacturers. The company has 16,048,734 shares of common stock outstanding as of November 12, 2025, and while not a direct relationship metric, the operational stability supported by these sites is crucial for maintaining investor and customer confidence.

The primary customer base that interacts with these service and sales channels includes:

• Orthopedists and sports medicine practitioners
• Physical therapists and chiropractors
• Athletic trainers
• Clinics and hospitals
• Professional sports teams and universities
• Retail distributors and OEM partners

The company's direct sales efforts also involve agreements with regional and national chains of physical therapy clinics and hospitals, as well as group purchasing organizations (GPOs). You should keep an eye on how the internal transition of therapeutic modalities production impacts service response times going forward, as this directly affects customer confidence.

Finance: draft 13-week cash view by Friday.

Dynatronics Corporation (DYNT) - Canvas Business Model: Channels

You're looking at how Dynatronics Corporation (DYNT) gets its medical products-like orthopedic soft bracing and physical therapy gear-into the hands of the practitioners who use them. The channel strategy relies heavily on intermediaries, though direct sales to larger entities are a known pressure point.

Exclusive sales through a network of dealers and distributors form the backbone of product movement. Dynatronics Corporation sells its products to a wide array of customers, including orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals, all facilitated through a network of independent dealers. This network is key for market reach across the United States.

Direct sales to OEM customers (though volume is decreasing) represent a segment facing headwinds. For the fiscal year ending June 30, 2025, Net Sales were reported at $27.39 million, which was a decrease of 15.8% from the prior year, with the decline attributed in part to a reduction in overall volume for OEM customers. This trend continued into the third quarter of 2025, where Net Sales were $7.02 million, a 7.6% decrease year-over-year, again citing a reduction in volume for OEM customers. This indicates a near-term challenge in the direct-to-manufacturer channel.

Retail distributors for certain product lines are explicitly mentioned as part of the customer base served via the dealer network. While specific revenue attributed only to retail distributors isn't broken out, the overall product mix shows the relative size of the main categories moving through these channels. For the three months ended September 30, 2025, the revenue split between the two main product categories was:

Product Category	Revenue (Three Months Ended 9/30/2025)
Physical Therapy and Rehabilitation Products	$4,161,586
Orthopedic Soft Bracing Products	$2,835,716

It's important to note that across fiscal years 2025 and 2024, no single product line accounted for more than 10% of total revenues, suggesting a diversified, albeit low-volume per-SKU, distribution strategy.

Company website and investor relations for corporate communication serve as the direct channel for financial stakeholders. You can track official updates via the Investor Relations section on the Dynatronics Corporation website. For instance, the Form 10-Q for the period ending September 30, 2025, was expected to be filed within a five-calendar-day extension period, as notified on November 17, 2025. The company reports its financial results, such as the Q3 FY2024 results released on May 9, 2024.

The primary customer types interacting with the distribution network include:

• Orthopedists
• Physical therapists
• Chiropractors
• Athletic trainers
• Sports medicine practitioners
• Clinics and hospitals

Dynatronics Corporation (DYNT) - Canvas Business Model: Customer Segments

You're looking at the core groups that buy products from Dynatronics Corporation as of late 2025. The company designs, manufactures, and markets its restorative products to a mix of clinical, athletic, and business-to-business channels. The customer base is geographically spread across the United States, Asia, Latin America, the Middle East, and other international locations.

The primary professional end-users are clearly defined:

• Physical therapists, orthopedists, and chiropractors
• Athletic trainers and sports medicine practitioners
• Clinics, hospitals, and rehabilitation facilities

Dynatronics Corporation also serves institutional and specialized athletic segments:

• Professional sports teams and university athletic programs

The company also sells to other businesses, specifically OEM customers (Original Equipment Manufacturers), which has shown a recent financial impact. For the three months ended September 30, 2025, Net Sales were $7.02 million. This represented a 7.6% decrease compared to the same period last year, which the company explicitly linked to a reduction in overall volume for OEM customers and softer demand in the orthopedic soft bracing category.

For the full fiscal year ending June 30, 2025, Dynatronics Corporation reported total Net Sales of $27.39 million, a decrease of 15.80% from the prior year's $32.53 million. This overall revenue decline was also attributed in part to the reduction in volume from OEM customers.

While direct revenue attribution by the listed professional segments isn't published, the product revenue split for the three months ended September 30, 2025, gives you an idea of what these segments are buying:

Product Category	Revenue (Three Months Ended September 30, 2025)
Physical Therapy and Rehabilitation Products	$4,161,586
Orthopedic Soft Bracing Products	$2,835,716

The company also markets and sells its products through retail distributors. The total number of shares outstanding as of November 12, 2025, was 16,048,734 common shares. This is the backdrop against which these customer segments operate.

Here is a summary of the identified customer types:

Customer Segment Category	Specific Examples/Notes
Clinical Professionals	Orthopedists, physical therapists, chiropractors
Athletic/Rehab Professionals	Athletic trainers, sports medicine practitioners
Facilities	Clinics, hospitals, rehabilitation facilities
Institutional/Team Sales	Professional sports teams, universities
Business-to-Business	OEM customers (volume reduction impacted FY 2025 sales)

The company also sells through retail distributors.

Dynatronics Corporation (DYNT) - Canvas Business Model: Cost Structure

You're looking at the hard numbers driving Dynatronics Corporation's operational expenses as of late 2025. Honestly, the cost structure is heavily influenced by non-operating charges right now, but the core operating costs tell a clear story of margin pressure and recent cost-cutting.

Cost of Goods Sold (COGS) is high; Gross Profit was only 21.9% of Net Sales in FY2025

The cost to make and deliver products is eating up the lion's share of revenue. For the fiscal year ended June 30, 2025, Dynatronics Corporation reported a Gross Profit of just 21.9% of Net Sales. This means that COGS represented approximately 78.1% of every sales dollar. To be fair, this low margin percentage was down from 23.5% of net sales in the prior fiscal year 2024. That compression is a major focus area for the cost structure.

Manufacturing and production costs (shifting from contract to internal)

While the specific cost breakdown related to the shift from contract manufacturing to internal production isn't itemized separately from COGS in the summary data, the low resulting gross margin percentage suggests that the current production setup-whether internal or contract-is inherently costly relative to current pricing. The strategic imperative here is clearly margin improvement, which hinges on optimizing these manufacturing and supply chain costs.

Selling, General, and Administrative (SG&A) expenses (currently being reduced)

On the overhead side, Dynatronics Corporation has made tangible progress in trimming fixed costs. SG&A expenses for the year ended June 30, 2025, were $8,464,000. That's a reduction of $1,444,000, or 14.6%, compared to the $9,908,000 recorded in fiscal year 2024. That's a solid cut, showing management is actively working to lower the operating expense base.

Here's a quick look at the key expense components for the most recent full fiscal year:

Cost/Expense Category	FY2025 Amount (Year Ended 6/30/2025)	FY2024 Amount (Year Ended 6/30/2024)
Gross Profit	$6,011,000	$7,635,000
Gross Profit as % of Net Sales	21.9%	23.5%
SG&A Expenses	$8,464,000	$9,908,000
Interest Expense, Net	$410,000	$418,000

Interest expense on debt, which was $67,207 in Q1 FY2026

Financing costs are a component of the overall cost structure. For the first quarter of fiscal year 2026, the reported interest expense was $67,207. [cite: User provided figure] This follows a trend of slight reduction, as the full fiscal year 2025 interest expense, net, was $410,000, down from $418,000 in fiscal year 2024. Lower debt balances are helping to keep this cost down.

Impairment charges, which drove the $10.90 million Net Loss in FY2025

The most significant driver of the bottom-line result was non-cash impairment charges. The Net Loss for fiscal year 2025 ballooned to $10,902,000, a sharp increase from the $2,698,000 net loss reported in FY2024. This was not an operating issue, but a significant write-down event. The total impairment charges recorded in FY2025 were substantial:

• Goodwill impairment charge: $7,117,000
• Intangible asset impairment charge: $950,000

These two items alone account for $8,067,000 of the total loss. The net loss attributable to common stockholders was even higher at $11,604,000 for FY2025.

Finance: draft 13-week cash view by Friday.

Dynatronics Corporation (DYNT) - Canvas Business Model: Revenue Streams

You're looking at the core ways Dynatronics Corporation brings in money, which is crucial for understanding its financial health as of late 2025. The primary revenue stream is product sales across its two main categories: Physical Therapy and Rehabilitation Products, and Orthopedic Soft Bracing Products.

For the full fiscal year 2025, Dynatronics Corporation reported total Net Sales of $27.39 million. That figure represented a 15.8% decrease from the prior year, which the company attributed to two main factors affecting revenue generation. One factor was a reduction in overall volume from OEM customers, and the other was a general softening in demand specifically within the orthopedic soft bracing product category. That's a tough environment to navigate, honestly.

To give you a clearer picture of the most recent performance, here's the breakdown for the first quarter of fiscal year 2026 (the three months ended September 30, 2025):

Revenue Stream Component	Q1 FY2026 Revenue Amount
Sales of Physical Therapy and Rehabilitation Products	$4,161,586
Sales of Orthopedic Soft Bracing Products	$2,835,716

If you add those two segments together, you get $7,001,902 in sales for that quarter, which aligns with the reported Q1 FY2026 sales of $7.02 million. See? The math checks out.

The dependency on Revenue from OEM customer volume is a significant factor in the revenue stream volatility you see in the numbers. The reports from late 2025 clearly indicate that a reduction in this OEM volume was a primary driver behind the decrease in both the Q3 FY2025 net sales and the full-year FY2025 net sales. This suggests that a portion of Dynatronics Corporation's revenue is tied to the ordering patterns and success of its original equipment manufacturer partners.

Another element feeding into the top line is the Sales of manufactured capital equipment and supplies. While specific revenue figures for only manufactured goods versus distributed goods for FY2025 aren't explicitly broken out in the latest reports, the company is actively working to change its production mix. Dynatronics Corporation is in the process of transitioning the production of the majority of its therapeutic modalities from contract manufacturers to internal operations. The goal here is to capture more margin by eliminating third-party markups and to gain better control over the supply chain, which directly impacts the cost side of the revenue equation.

The revenue streams for Dynatronics Corporation can be summarized by the key product areas contributing to sales:

• Physical Therapy and Rehabilitation Products
• Orthopedic Soft Bracing Products
• Sales derived from OEM customer volume
• Sales of internally manufactured equipment and supplies

The company's product portfolio is broad, covering orthopedic soft bracing, physical therapy and rehabilitation products, therapeutic modalities, and treatment tables. No single product accounted for more than 10% of total revenues in fiscal years 2025 or 2024. Finance: draft 13-week cash view by Friday.